Live Feeds
● TRACKER Updated 7d ago · 35 sources tracked

Towards Conversational AI for Disease Management

Artificial intelligence is moving from administrative support to specialized diagnostic and educational tools. Researchers at the Johns Hopkins Kimmel Cancer Center validated DELFI, an AI-powered blood test that identifies liver cancer, potentially reducing the need for invasive biopsies. In medical education, West Virginia University researchers are testing ChatGPT-5 Pro to generate psychiatry training cases. While AI shows strength in diagnosis, a tension remains between the technology's tendency to converge on likely answers and the medical need to identify rare conditions.

RSS Source map (38)

What changed

The introduction of the DELFI blood test for liver cancer and the use of ChatGPT-5 Pro for psychiatry training cases expand AI's clinical footprint.

Live updates

  1. AI Blood Tests and Education Tools Expand Clinical Utility

    Artificial intelligence is moving from administrative support to specialized diagnostic and educational tools. Researchers at the Johns Hopkins Kimmel Cancer Center validated DELFI, an AI-powered blood test that identifies liver cancer, potentially reducing the need for invasive biopsies. In medical education, West Virginia University researchers are testing ChatGPT-5 Pro to generate psychiatry training cases. While AI shows strength in diagnosis, a tension remains between the technology's tendency to converge on likely answers and the medical need to identify rare conditions.

    Why it matters

    These developments follow a trend of AI assisting with clinical decisions and designing new molecules for pulmonary fibrosis. The shift toward non-invasive diagnostics like DELFI addresses the risks associated with traditional gold-standard biopsies. Integrating AI into psychiatric training reflects a broader effort to scale mental health support and education.

    What is confirmed

    • Researchers at the Johns Hopkins Kimmel Cancer Center validated an AI-powered blood test called DELFI to pinpoint liver cancer.
    • West Virginia University researchers used ChatGPT-5 Pro to evaluate its ability to create psychiatry education cases.

    Still unconfirmed

    • AI is effective at diagnosing health problems but less capable than doctors at weighing treatment options.

    What to watch next

    • Clinical adoption rates of the DELFI test compared to traditional liver biopsies.
    • Peer-reviewed results from West Virginia University regarding the accuracy of AI-generated psychiatry cases.
    Sources used for this update (6)
    1. www.psychologytoday.com — Why Every Patient Needs an AI Zebra Scan
    2. www.thetechedvocate.org — NeuroLipoX: The Astonishing Weight Loss Breakthrough of 2026 Reshaping Lives
    3. www.thetechedvocate.org — This Breakthrough AI Blood Test Finds Liver Cancer Earlier — Here’s How
    4. www.thetechedvocate.org — This Game-Changing AI Blood Test Could Replace Painful Liver Biopsies
    5. medicalxpress.com — AI creates psychiatry training cases, but human oversight remains essential
    6. www.wsbradio.com — AI is now very good at diagnosing health problems, but doctors are still better at weighing treatment options
    confidence 85%

  2. AI Expands into Drug Discovery and Clinical Decision Support

    Artificial intelligence is shifting from administrative tasks to direct clinical application. AI now assists doctors with clinical decisions, identifies mental health risks earlier, and extends care via wearables and smartphones. Beyond diagnostics, algorithms are designing new molecules for pulmonary fibrosis that are currently in clinical trials. These advancements occur alongside a new CMS framework for healthcare interoperability, though providers must still meet a baseline interoperability level to participate in the network. This transition aims to connect and interpret vast amounts of healthcare data in real time to improve intelligence.

    Why it matters

    Previous reports focused on consumer-facing health assistants and the limitations of chatbots in mental health. The shift toward drug discovery and clinical decision support represents a move into high-stakes medical intervention. Interoperability standards are necessary to ensure these AI tools can access the data required to function across different health systems.

    What is confirmed

    • AI is helping doctors make clinical decisions and identify mental health risks earlier.
    • AI is expanding healthcare access through smartphones and wearable devices.

    Still unconfirmed

    • The CMS framework allows a gentle opt-in but requires a baseline level of interoperability for network participation.

    What to watch next

    • Clinical trial results for AI-designed pulmonary fibrosis molecules
    • Verification of Alzheimer's early-stage cure claims
    • Implementation data on the CMS interoperability baseline
    Sources used for this update (6)
    1. medcitynews.com — A New Era of Interoperability, But Who Gets Left Behind?
    2. www.thetechedvocate.org — This Breakthrough AI Alzheimer’s Research Just Found a Cure for Early Stages
    3. www.thetechedvocate.org — Unbelievable: AI Just Created a Drug That Could End Pulmonary Fibrosis
    4. news.gatech.edu — From Diagnosis to Wellness, AI's Healthcare Revolution
    5. www.expresshealthcare.in — Ayushman Bharat covers seniors above 70. Are governmental schemes alone enough to secure their care?
    6. www.forbes.com — How Real-Time Interoperability And AI Are Rebuilding Healthcare Intelligence
    confidence 70%

  3. AI Advances in Drug Discovery and Clinical Decision Support

    Artificial intelligence is expanding from administrative tasks to active clinical roles and drug creation. Researchers report that AI now assists doctors with clinical decisions and the early identification of mental health risks. In drug discovery, AI has developed new molecules for pulmonary fibrosis currently in clinical trials. These tools are integrating with smartphones and wearables to broaden healthcare access. Meanwhile, the Centers for Medicare & Medicaid Services has introduced an interoperability framework requiring a baseline standard for network participation to improve real-time data interpretation.

    Why it matters

    The transition to AI-driven care aims to reduce gaps in healthcare access and improve treatment for previously untreatable conditions. This shift relies on the ability of different systems to share and interpret patient data in real time.

    What is confirmed

    • AI helps doctors make clinical decisions and identify mental health risks earlier.
    • AI-designed drugs for pulmonary fibrosis are moving through clinical trials as of July 2026.
    • The CMS interoperability framework requires participants to meet a baseline level of interoperability to join the network.

    Still unconfirmed

    • AI research has found a cure for early stages of Alzheimer's disease.
    • Financial health cover for India's elderly requires support from technology and private insurance.

    What to watch next

    • Clinical trial results for AI-designed pulmonary fibrosis molecules
    • Adoption rates of the CMS interoperability baseline standards
    Sources used for this update (6)
    1. medcitynews.com — A New Era of Interoperability, But Who Gets Left Behind?
    2. www.thetechedvocate.org — This Breakthrough AI Alzheimer’s Research Just Found a Cure for Early Stages
    3. www.thetechedvocate.org — Unbelievable: AI Just Created a Drug That Could End Pulmonary Fibrosis
    4. news.gatech.edu — From Diagnosis to Wellness, AI's Healthcare Revolution
    5. www.expresshealthcare.in — Ayushman Bharat covers seniors above 70. Are governmental schemes alone enough to secure their care?
    6. www.forbes.com — How Real-Time Interoperability And AI Are Rebuilding Healthcare Intelligence
    confidence 80%

  4. Tech Giants Integrate AI Health Assistants Amid Mental Health Limitations

    Samsung has integrated an AI-powered personal health assistant into its Samsung Health platform. However, research indicates AI chatbots still struggle with most mental health conditions. These developments follow earlier reports of AI potential in diagnosis and treatment.

    Still unconfirmed:

    • Samsung released a fully integrated AI-powered personal health assistant within the Samsung Health platform.
    • AI chatbots still struggle with most mental health conditions despite better detection of suicidal ideation.
    Sources used for this update (4)
    1. Medicare For All? Not So Fast.
    2. Samsung Launches AI Health Assistant, Indicating A Growing Trend Among Tech Giants – Forbes
    3. For most mental health conditions, AI remains a liability, research finds
    4. Wellworks For You Releases White Paper Reframing Wellness ROI Around Personalization and Cost Containment
    confidence 70%

  5. Medical AI Agents Show Progress but Lack Clinical Readiness

    Recent studies on agentic AI models indicate potential to assist in diagnosis, treatment, and hospital admissions. Despite these capabilities, these models are not yet prepared for real-world clinical application. Current benchmarks are criticized for lacking actual patient environments.

    What's confirmed:

    • Agentic AI models could assist with patient management stages including diagnosis, treatment, and hospital admission.
    • Neither agentic AI model is ready for real-world clinical use.

    Still unconfirmed:

    • Two medical AIs beat doctors in Nature benchmarks within environments that lacked patients.
    Sources used for this update (4)
    1. Yidu Tech Achieves Its First Full-Year Profit: FY2026 Net Profit Reaches RMB 78.8 Million, with Positive Operating Cash Flow in the Second Half
    2. The Last Mile Problem In Healthcare AI
    3. Agents AMIE and MIRA advance medical AI capabilities - Nature
    4. Nobody fails in the sandbox - by Alex Rivero
    confidence 90%

  6. Google's AMIE AI Shows Potential in Disease Management Simulations

    Google's AMIE system can match or exceed primary care physicians in disease management within simulated environments. A separate real-world trial of a generative AI support tool improved clinical decision-making quality but did not alter short-term patient outcomes. These developments follow recent research published in Nature.

    What's confirmed:

    • Google's AMIE system demonstrates the potential to match or surpass primary care physicians in disease management within simulated environments.
    • Research regarding AMIE was published in the journal Nature.

    Still unconfirmed:

    • AI has surpassed doctors in real EHR processes and multi-round disease management.
    • AI outperforms physicians but not at actual medicine.
    • A generative AI support tool in primary care was safe and improved decision-making quality without changing short-term patient outcomes.
    • Chuck Hemann is the new chief business, AI officer at Assembled Intelligence.
    Sources used for this update (7)
    1. Healthcare comms platform Assembled Intelligence names chief business, AI officer
    2. Clinical trial evaluates generative AI support tool in primary care
    3. [AI Commentary] Google's Medical AI "AMIE" Moves Toward Long-term ...
    4. More Studies Show AI Outperforms Physicians, Just Not at Medicine
    5. Google's AI system achieves clinical management performance comparable ...
    6. Towards Conversational AI for Disease Management - 道客巴巴
    7. 论文速递 2026-06-25 — BioTender
    confidence 80%

  7. Google AMIE and MIRA Match Physician Performance in Nature Study

    Two AI models, Google's AMIE and MIRA, demonstrated the ability to assist with patient management from diagnosis to treatment. Research published in Nature shows these conversational tools perform at least as well as doctors in simulated settings. AMIE is not yet ready for clinical use and requires real-world testing.

    What's confirmed:

    • Research published in Nature on June 17, 2026, presents two AI models, AMIE and MIRA, that can assist with diagnosis and treatment decisions.
    • AMIE and MIRA perform at least as well as physicians in simulated clinical settings.
    • AMIE scored higher than primary care physicians on measures of investigation precision, treatment precision, guideline alignment, and plan appropriateness.
    • AMIE is not ready for clinical use and needs prospective real-world testing.
    Sources used for this update (9)
    1. Two new medical AIs for diagnosis and treatment ... - Medical Xpress
    2. Google's AMIE beats doctors on key simulated disease-management tasks
    3. Google AMIE Matches Doctors in Nature Study · iCharles
    4. AMIE: How Conversational AI Is Moving Beyond Diagnosis to Disease ...
    5. AMIE and MIRA: A Reality Check on the Latest Medical AI Claims
    6. Google's AMIE and MIRA: New AI Models Match Physician Performance in ...
    7. AI medical tools such as Google's 'A… - GIGAZINE（ギガジン）
    8. Trend Analysis: Conversational AI for Disease Management
    9. How AI integration into real-world tasks enhances healthcare and education
    confidence 100%

  8. Google's AMIE AI Matches Doctors in Disease Management Reasoning

    Google Research developed the Articulate Medical Intelligence Explorer (AMIE), an agentic system for multi-visit clinical management. A study published in Nature indicates AMIE is non-inferior to primary care physicians in management reasoning. The system uses Gemini for long-context reasoning to align with clinical guidelines and drug formularies.

    What's confirmed:

    • AMIE was compared to 21 primary care physicians across 100 multi-visit case scenarios in a randomized, blinded virtual OSCE study.
    • Specialists assessed AMIE as non-inferior to primary care physicians in management reasoning.
    • AMIE scored better than physicians in treatment and investigation preciseness and alignment with clinical guidelines.
    • The system utilizes Gemini's long-context capabilities and a two-agent architecture consisting of a Dialogue Agent and a Management Reasoning Agent.
    • A new RxQA benchmark of 600 multiple-choice questions from national drug formularies was used to evaluate medication reasoning.
    • The research was published in Nature on 17 June 2026.

    Still unconfirmed:

    • MIRA integrates with electronic health records to request diagnostic tests and recommend hospital admissions.
    Sources used for this update (13)
    1. Towards autonomous medical artificial intelligence agents
    2. Agentic AI Comes to Medicine
    3. AI medical tools match or surpass doctors for advice
    4. New research shows how AMIE, our medical AI, could help manage health conditions.
    5. Towards Conversational AI for Disease Management
    6. Towards Conversational AI for Disease Management - Nature
    7. Towards Conversational AI for Disease Management - PubMed
    8. Google advances its AMIE research medical AI from diagnosis to treatment
    9. Towards Conversational AI for Disease Management
    10. Articles in 2026 - Nature
    11. Google advances AMIE toward longitudinal disease management
    12. expert reaction to presentation of two new medical AI models for ...
    confidence 100%